AVID Medical recalls (Class 1 device correction) certain organ recovery and medical convenience kits.
FDA cites Aurobindo Pharma USA for multiple failures to comply with federal drug supply chain security requirements, including delays in reporting stolen prescription drugs to the agency.
AVID Medical recalls (Class 1 device correction) certain organ recovery and medical convenience kits.
FDA cites Aurobindo Pharma USA for multiple failures to comply with federal drug supply chain security requirements, including delays in reporting stolen prescription drugs to the agency.
FDA tells Aquestive Therapeutics that deficiencies have been identified in the company’s NDA for Anaphylm that currently preclude labeling and post-marketing commitments discussions.
FDA grants Alessa Therapeutics a fast track designation for Enolen, an experimental localized prostate cancer therapy.
